
News|Articles|October 1, 2012
Current standards and future treatments of rheumatoid arthritis
Rheumatoid arthritis is an autoimmune disorder in which the immune system targets synovial joints and causes mild-to-severe joint disease with extra-articular manifestations. This review discusses the current standards of care and details the data being collected on new agents.
Advertisement
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Growth of GLP-1 therapies has reshaped the market | PBMI 2026
2
Judi Health, Employers Health team up to launch new PBM solution
3
Deborah Dempsey, Pharm.D., MBA, RPh, on 340B discounts vs. rebates | PBMI 2026
4
Navitus launches GLP-1 drug management programs
5

















